Utilities were generated from the ipilimumab MDX010-20 trial ( Clinicaltrials.gov Identifier : NCT00094653 ) using the condition-specific EORTC QLQ-C30 ( via the EORTC-8D ) and generic SF-36v2 ( via the SF-6D ) preference-based measures .